propidium has been researched along with lissamine rhodamine b in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessio, E; Bergamo, A; Furlani, A; Gagliardi, R; Mestroni, G; Sava, G; Scarcia, V | 1 |
| Fiebig, HH; Kelter, G | 1 |
2 other study(ies) available for propidium and lissamine rhodamine b
| Article | Year |
|---|---|
In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Survival; Cisplatin; Dimethyl Sulfoxide; DNA, Neoplasm; Flow Cytometry; Humans; KB Cells; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Neoplasm Transplantation; Organometallic Compounds; Propidium; Rhodamines; Ruthenium Compounds; Tumor Cells, Cultured | 1999 |
Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Dose-Response Relationship, Drug; Humans; Plant Extracts; Plant Proteins; Propidium; Rhodamines | 2006 |